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A 45-year-old man with left renal mass underwent nephrectomy to reveal a 20-cm tumor diagnosed as
sarcomatoid chromophobe renal cell carcinoma. Lymph node metastasis of chromophobe and sarco-
matoid components, disseminated tumor in retroperitoneal fat, lymphatic vessels, and perirenal adipose
tissue in lymphangitic carcinomatosis pattern were identiﬁed. Chromophobe epithelial cells were pos-
itive for epithelial membrane antigen, c-Kit, and cytokeratin 7; sarcomatoid cells were positive for CD10
and smooth muscle antigen with high proliferation index. Chromophobe epithelial cells had loss of
heterozygosity in chromosomes 1p and 1q, whereas sarcomatoid cells had loss of heterozygosity in 3p,
1p, and 1q. In conclusion, sarcomatoid chromophobe renal cell carcinoma has aggressive biologic
behavior and potential to metastasize in unusual patterns.
Published by Elsevier Inc.Open access under CC BY-NC-ND license.Introduction
Malignant kidney tumors account for 2% of cancer incidence and
mortality in the United States, and studies show increased inci-
dence worldwide.1 The chromophobe subtype is rare, constituting
5% of renal cell carcinoma (RCC). Overall, chromophobe renal cell
carcinoma (CRCC) has favorable prognosis when compared with
conventional clear cell type.2 Sarcomatoid transformation in RCC
portends poor prognosis, with median survival of 4-9months after
diagnosis.3We report a unique case of sarcomatoid transformation
in CRCC to further characterize this rare entity.Case presentation
A 45-year-old man presented to the National Institutes of Health
with a 6-year history of a left renal mass. The mass was discovered
incidentally in 2006, at which time it was reported as a 12-cmby the Intramural Research
: þ1-301-480-9488.
no).
 CC BY-NC-ND license.hyperdense cystic lesion that was interpreted as being benign. In
the interim, he was followed up by imaging only, with interval
growth. In May 2012, he was referred to the National Institutes of
Health for consideration in a protocol, and magnetic resonance
imaging showed a 16-cm solid left renal mass. Biopsy of the renal
mass conﬁrmed the diagnosis of RCC. Subsequently, the patient
underwent a radical left nephrectomy.
Gross examination showed a 20-cm, 1600-g spherical encap-
sulated tumor mass with a variegated hemorrhagic and ﬁrmwhite
cut surface with irregular borders. Microscopic evaluation of the
tumor revealed 2 distinct morphologies (Fig. 1A). Speciﬁcally,
areas characteristic of CRCC were intermixed with a spindle cell
proliferation consistent with sarcomatoid dedifferentiation. The
CRCC had morphology typical of this tumor, with large cells
exhibiting abundant clear cytoplasmwith distinct cell borders and
irregular nuclei with occasional prominent small nucleoli. The
spindle cell component was diffusely admixed with nests of
chromophobe neoplastic cells and comprised approximately 50%
of the tumor mass. The spindle cells were arranged in loose fas-
cicles of pleomorphic spindle-shaped cells with high cellularity
and atypia (Fig. 1B). In addition, there were areas of hemorrhage,
necrosis, sclerotic stroma, vascular invasion, and the tumor
permeated the capsule. Three of 50 lymph nodes were positive for
metastatic tumord2 of 40 periaortic lymph nodes were positive
for both spindle and chromophobe cell components, and 1 of 10
hilar lymph nodes was positive for only the chromophobe cell
component (Fig. 1C). There were multiple foci of disseminated
Figure 1. (A-D): Chromophobe renal cell carcinomad2 distinct morphologies. Epithelial tumor cells are admixed with sarcomatoid tumor cells (A, 100), spindle cell/sarcomatoid
tumor cells (B, 400). Metastatic chromophobe renal cell carcinoma to lymph node (C, 200). Tumor involvement of a lymphatic vessel in the perirenal adipose tissue (D:
H&E, 40), inset shows spindle cell tumor inﬁltration of muscle and adipose tissue in perirenal soft tissue (H&E, 100).
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vessels and inﬁltrating adipose tissue (Fig. 1D). The residual left
kidney showed chronic interstitial nephritis. The ureter and
vascular margins were free of tumor. The ﬁnal TNM classiﬁcation
was rendered as pT3pN2pMX.
The tumor displayed 2 distinct immuhistochemical proﬁles of
its 2 components (Fig. 2A-F). The chromophobe neoplastic cells
were positive for c-Kit (CD117), cytokeratin 7, and epithelialFigure 2. (A-F): Distinct immunophenotype of the 2 components of this tumor. The chromo
membrane antigen (C, 100), which are negative in the spindle cell component. The spindl
which are negative in the chromophobe component. MIB-1 (Ki-67) immunostain demonstrmembrane antigen, whereas the sarcomatoid neoplastic cells
were positive for CD10 and smooth muscle antigen. MIB-1 (Ki-67)
immunostain demonstrated a higher proliferation index in sar-
comatoid regions (Fig. 2F).
Both chromophobe and spindle cell components were eval-
uated by electron microscopy. Ultrastructural features typical of
CRCC, such as cytoplasmic vesicles and abundant mitochondria
with disrupted, tubulovesicular, or absent cristae were seen inphobe component is positive for c-Kit (A, 100), cytokeratin 7 (B, 100), and epithelial
e cell component is positive for CD10 (D, 100) and smooth muscle antigen (E, 100),
ates a high proliferation index in the spindle cell component (F, 100).
Figure 3. Tumor cells of spindle cell morphology displayed loss of heterozygosity (LOH) in chromosome 3p, whereas the epithelial tumor component did not.
M. Alimchandani et al. / Urology Case Reports 2 (2014) 39e42 41the chromophobe component, in addition to multiple contig-
uous intercellular attachments consistent with epithelial differ-
entiation. The spindle cell component exhibited ultrastructural
features consistent with 2 distinct cell populations, one being
myoﬁbroblastic with subplasmalemal ﬁlaments and abundant
rough endoplasmic reticulum and the other being consistent
with a chromophobe cell phenotype, as shown by the presence
of abundant abnormal mitochondria.
Normal, epithelial, and sarcomatoid components of tumor
were microdissected and deoxyribonucleic acid extracted for
loss of heterozygosity (LOH) analysis using polymorphic markers
for chromosomes 3p25, 1p35-36, and 1q42-43. There was LOH
in chromosomes 1p and 1q in tumor cells of typical chromo-
phobe morphology. In contrast, tumor cells of spindle cellmorphology displayed LOH in chromosomes 3p (Fig. 3) in
addition to 1p and 1q.
Discussion
Chromophobe subtype of RCC is uncommon, and its sarco-
matoid dedifferentiation is rare. Few cases of sarcomatoid CRCC
have been reported.4,5 The mean age of presentation of sarco-
matoid CRCC is higher than sarcomatoid clear cell RCC, sug-
gesting that sarcomatoid change occurs in long-standing CRCCs,
such as in our current case. Sarcomatoid component represents
poorly differentiated transformation that occurs in any histo-
logic subtype.6,7 Clinicopathologic studies conﬁrm that sarco-
matoid transformation is associated with dismal prognosis. It is
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differentiation in the most common subtype of RCC, that is,
clear cell type, and there is limited information about sarco-
matoid change in the chromophobe subtype.
Metastasis of CRCC is deemed rare. Contrary to the belief that it
is usually the sarcomatoid component that metastasizes to lymph
nodes,5,8 we ﬁnd lymph node metastasis of both chromophobe and
spindle cell components.
An unexpected ﬁnding in the current case is the unusual
pattern of lymphangitic spread. Multiple foci of the sarcomatoid
tumor were in lymphatic vessels and permeating retroperitoneal
and perirenal adipose tissue. We considered lymphangiosarcoma
in our differential diagnosis. However, morphologic comparison
with the primary renal tumor and immunophenotype (cytokeratin
AE1/AE3 positivity) was in favor of lymphangitic carcinomatosis by
sarcomatoid CRCC. There are only few instances of lymphangitic
carcinomatosis of clear cell RCC.9,10
The chromophobe and spindle cells demonstrate distinctive
immunohistochemical proﬁles. The sarcomatoid cells are positive
with smooth muscle antigen, suggesting myoﬁbroblastic differen-
tiation, and with CD10 and cytokeratin AE1/AE3, indicative of an
epithelial/chromophobe cell nature.
The electron microscopic features support the immunohisto-
logic proﬁle of the tumor cells. They conﬁrmed the chromophobe
nature of the epithelial cells, characterized by intracytoplasmic
vesicles and increased numbers of mitochondria with tubulove-
sicular cristae,11 and the dual phenotype of the spindle cells, as
myoﬁbroblastic12 and chromophobe. Although studies have used
electron microscopy as an important ancillary technique to
characterize RCC subtypes,11,13 ultrastructural characterization of
the sarcomatoid component has been limited,14 and we are not
aware of any other case of sarcomatoid CRCC in which the sar-
comatoid cells retain features typical of chromophobe cells.
Our genetic studies revealed LOH in 3p in addition to 1p and 1q
in regions of sarcomatoid morphology. Loss of 3p is frequently seen
in clear cell type RCC. Our ﬁndings suggest that loss of 3p in CRCC
correlates with biologic aggressiveness.
Although CRCC is associated with a better prognosis than clear
cell RCC, it is important for the pathologist to recognize a subset of
CRCC that has aggressive biologic behavior. Our case report addsinformation critical to better characterization of sarcomatoid
CRCCdwith widespread metastasis in lymph nodes and lymphatic
vessels in a lymphangitic carcinomatosis pattern of tumor
involvement.References
1. National Cancer Institute, Surveillance Epidemiology and End Results database.
http://seer.cancer.gov/statfacts/html/kidrp.html.
2. Cheville JC, Lohse CM, Zincke H, et al. Comparisons of outcome and prognostic
features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol.
2003 May;27:612e624.
3. de Peralta-Venturina M, Moch H, Amin M, et al. Sarcomatoid differentiation in
renal cell carcinoma: a study of 101 cases. Am J Surg Pathol. 2001 Mar;25:275e
284.
4. Parada D, Peña K, Moreira O. Sarcomatoid chromophobe renal cell carci-
noma. A case report and review of the literature. Arch Esp Urol. 2006
Mar;59:209e214.
5. Abrahams NA, Ayala AG, Czerniak B. Chromophobe renal cell carcinoma with
sarcomatoid transformation. Ann Diagn Pathol. 2003 Oct;7:296e299.
6. Cheville JC, Lohse CM, Zincke H, et al. Sarcomatoid renal cell carcinoma: an
examination of underlying histologic subtype and an analysis of associations
with patient outcome. Am J Surg Pathol. 2004 Apr;28:435e441.
7. Shuch B, Bratslavsky G, Linehan WM, Srinivasan R. Sarcomatoid renal cell
carcinoma: a comprehensive review of the biology and current treatment
strategies. Oncologist. 2012;17:46e54.
8. Kuroda N, Tamura M, Hes O, et al. Chromophobe renal cell carcinoma with
prominent lymph node metastasis and polysomy of chromosome 21: poorly
differentiated form or “presarcomatoid” form? Med Mol Morphol. 2011 Sep;44:
168e173.
9. Wallach JB, McGarry T, Torres J. Lymphangitic metastasis of recurrent renal cell
carcinoma to the contralateral lung causing lymphangitic carcinomatosis and
respiratory symptoms. Curr Oncol. 2011 Jan;18:e35ee37.
10. Guddati AK, Marak CP. Pulmonary Lymphangitic Carcinomatosis due to
Renal Cell Carcinoma. Case Rep Oncol. 2012 May;5:246e252. Epub 2012
May 15.
11. Abrahams NA, MacLennan GT, Khoury JD, et al. Chromophobe renal cell car-
cinoma: a comparative study of histological, immunohistochemical and ultra-
structural features using high throughput tissue microarray. Histopathology.
2004 Dec;45:593e602.
12. Eyden B. The myoﬁbroblast: an assessment of controversial issues and a
deﬁnition useful in diagnosis and research. Ultrastruct Pathol. 2001 Jan-Feb;25:
39e50.
13. Krishnan B, Truong LD. Renal epithelial neoplasms: the diagnostic impli-
cations of electron microscopic study in 55 cases. Hum Pathol. 2002 Jan;33:
68e79.
14. Li L, Teichberg S, Steckel J, Chen QH. Sarcomatoid renal cell carcinoma with
divergent sarcomatoid growth patterns: a case report and review of the liter-
ature. Arch Pathol Lab Med. 2005 Aug;129:1057e1060.
